Objective and designTo investigate the healing mechanism of Delonix regia galactomannan (GM-DR) in a mice model of excisional cutaneous wound.
Materials and subjectsFemale Swiss mice were used in all treatments.Treatment GM-DR (% 0.01-1) was topically applied to the wounds during 14 days.
MethodsThe wound healing effect of GM-DR was evaluated by the following parameters: wound closure, clinical signs (hyperemia, edema, exsudate, nociception), oxidative stress markers (malondialdehyde -MDA, reduced glutathione -GSH), histopathological and histomorphometric analysis (collagenesis, blood vessels, polymorphonuclear, mononuclear, broblast/myo broblast cells) and immunohistochemical (in ammatory growth factor mediators).
ResultsGM-DR reduced wound area (7 -14 th day) and hypernociception (6 h -5 th day), leukocyte in ltration (2 -7 th day), expression and levels of IL-1β (2 th day), IL-6 (2 th day), MDA (44% -2 th day), and increased broblast/myo broblast, granulation tissue, collagen deposition, GSH (25 -50%, 2-5 th day), Transforming Growth Factor Beta (TGF-β) expression (7-10 th day) and Smooth Muscle Alpha Actin (a-SMA) (7-14 th day).
ConclusionsGM-DR accelerates the mice healing process acting both in the in ammatory and proliferative phases.